TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›COCO
COCO logo

COCO

Vita Coco Company, Inc.

Last earnings +29.7% on 2026-04-29

Hold
$66.16
▼ -8.78%
$66.16▲ +87.74%
over 1Y
L $32.30H $84.02
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today-8.8%
1W-19.9%
1M-11.1%
3M+37.1%
YTD+23.8%
1Y+87.7%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
B
Valuation
Overvalued
Filings
Watch
Hold
Conviction
Horizon
Medium (3–12mo)
12-mo target
$•••
Street · 17 analysts
Buy

Debt-free coconut-water leader growing 18% with 21% ROE — a high-quality brand, but priced for perfection at 70x.

Revenue $610M · FY2025

The read

Middling fundamentals and a rich price (~32% above fair value) leave little margin of safety — a wait-and-see.

Vita Coco is the dominant brand in the fast-growing coconut-water category, and the business quality is excellent. FY2025 revenue rose 18.2% to $610M, net income grew 27.5% to $71.3M, and diluted EPS climbed 26.6% to $1.19, continuing a steady multi-year ramp (net income from $19M in FY2021 to $71.3M in FY2025). The model is capital-light and pristine financially: a 36.5% gross margin, 13.5% operating margin, a 21.5% return on equity, and a debt-free balance sheet (0.39x liabilities/equity) with $197M of cash. This is a genuine consumer-staples growth brand riding the secular shift toward better-for-you, functional beverages.

The concerns are concentration and price. The 10-K flags that two customers accounted for roughly 44% of consolidated net sales — a meaningful dependence on a handful of large retail/club partners — and warns that new and revised U.S. tariffs on its principal sourcing countries have already increased costs and created significant uncertainty for a company that imports coconut water from abroad. Operating income grew a more modest 11.8% versus 27.5% net-income growth, hinting that some of the bottom-line strength came from below-the-line items rather than pure operating leverage, and gross margin growth (+12.0%) lagged revenue (+18.2%), consistent with cost/tariff pressure.

Is COCO a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Covered call~60d expiry
  • Long 100 shares @ ~66.16
  • Short call 69 @ ~5.82 est
debit $6,034max +$866max −$6,033BE 60.34

HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.

Open in the calculator →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$380M$428M$494M$516M$610M
Gross profit$113M$103M$181M$199M$223M
Operating income$24.6M$3.06M$56.5M$73.8M$82.5M
Net income$19.0M$7.81M$46.6M$56.0M$71.3M
Diluted EPS$0.35$0.14$0.79$0.94$1.19
Net margin5.0%1.8%9.4%10.8%11.7%

10-year statements — income, cash flow, balance sheet & CSV export →

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$3.58B
EV / EBITDA42.8
EV / Sales5.9
EV / FCF91.8
P / FCF96.8
PEG (trailing)2.02
Earnings yield1.9%
FCF yield1.0%

Quality & risk

ROIC (est.)19.7%
Free cash flow$39.0M
Total debt—
Net cash$197M
Altman Z-Score20.89 safe
Piotroski F-Score4/8

Capital returns

Buyback yield0.3%
Dividend yield (est.)—
Shareholder yield0.3%
Shares Δ YoY+0.2%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Some governance/structural items recently, but no outright red flags.
  1. 8-K Shareholder vote2026-06-04
  2. 8-K Earnings results2026-04-29
  3. 10-Q Quarterly report2026-04-29
  4. 8-K/A Amended 8-K2026-04-22
  5. DEF 14A Proxy statement2026-04-22
  6. 8-K Officer / director change2026-04-10
  7. 8-K Earnings results2026-02-18
  8. 10-K Annual report2026-02-18
  9. 8-K Officer / director change2026-01-08

Recent filings

all on EDGAR ↗
4Period ending 2026-06-172026-06-18open ↗144Filing2026-06-17open ↗4Period ending 2026-06-122026-06-15open ↗4Period ending 2026-06-112026-06-12open ↗4Period ending 2026-06-112026-06-12open ↗144Filing2026-06-11open ↗144Filing2026-06-11open ↗4Period ending 2026-06-032026-06-05open ↗4Period ending 2026-06-032026-06-05open ↗4Period ending 2026-06-032026-06-05open ↗4Period ending 2026-06-032026-06-05open ↗4Period ending 2026-06-032026-06-05open ↗

Quality score

B
ValueGrowthProfitHealthMom.
ValueD
GrowthA
ProfitabilityB+
Financial healthA-
MomentumC
  • ✓Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✓Net margin above 10%
  • ✓Return on equity above 15%
  • ✓Liabilities below 2× equity
  • ✗P/E below 25

Fair value est.

$45.22

Overvalued -32% vs price

cheapfair valueexpensive

Modified Graham: EPS $1.19 × (8.5 + 1.5 × 22.0% growth) × 1.10 quality = 38.0× multiple. An estimate, not a price target.

32.3052-week84.02
Revenue
$610M
+18.2% YoY
Net margin
11.7%
ROE
21.5%
P/E
55.6

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$610M+18.2%
Net income$71.3M+27.5%
Gross profit$223M+12.0%
Operating income$82.5M+11.8%
Diluted EPS$1.19+26.6%
Cash & equivalents$197M+19.6%
Total assets$461M+27.3%
Total liabilities$130M+25.2%
Stockholders' equity$332M+28.1%
Gross: 36.5%Op.: 13.5%L/E: 0.39x

Frequently asked

Is Vita Coco Company, Inc. (COCO) a buy?
COCO currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. Debt-free coconut-water leader growing 18% with 21% ROE — a high-quality brand, but priced for perfection at 70x.
What is COCO's fair value?
A Modified-Graham model based on COCO's SEC fundamentals estimates a fair value of about $45.22. It is an estimate from reported earnings, not a price target.
Is COCO overvalued or undervalued?
Against a Modified-Graham fair-value estimate, COCO currently appears overvalued relative to its SEC-grounded earnings power.
What is Vita Coco Company, Inc.'s quality score?
COCO scores 70.1067440211155/100 (grade B) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001482981, latest 10-Q filed 2026-04-29) · EODHD · Proprietary analysis · as of 6/21/2026, 9:01:08 PM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

AI-generated analysis, produced by our proprietary engine from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 21, 2026, 5:01 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC

Last 90 days: 0 open-market buys · 6 sales

2026-06-17
Sadowsky Kenneth
Director
Sell3.90K @ $82.92$323K
2026-06-12
Liran Ira
Director
Sell74.2K @ $80.29$5.96M
2026-06-12
Liran Ira
Director
Sell73.8K @ $80.32$5.93M
2026-06-11
Liran Ira
Director
Sell95.8K @ $79.14$7.58M
2026-06-11
Liran Ira
Director
Sell96.2K @ $79.14$7.61M
2026-06-11
Burth Jonathan
Chief Operating Officer
Exercise23.6K @ $10.18$240K
2026-06-11
Burth Jonathan
Chief Operating Officer
Exercise6.42K @ $10.18$65.4K
2026-06-11
Burth Jonathan
Chief Operating Officer
Sell30.0K @ $80.00$2.40M
2026-06-03
Liran Ira
Director
Award1.53K @ $75.18$115K
2026-06-03
Morreau Jane Cecil
Director
Award1.53K @ $75.18$115K
2026-06-03
Sadowsky Kenneth
Director
Award1.53K @ $75.18$115K
2026-06-03
Dozie Aishetu Fatima
Director
Award1.53K @ $75.18$115K

Earnings history

beat/miss · move
2026-04-29Beat +53.5% est▲ +7.27%8-K ↗
2026-02-18Miss -28.5% est▲ +7.60%8-K ↗
2025-10-29Beat +30.8% est▲ +2.26%8-K ↗
2025-07-30Beat +2.8% est▼ -6.67%8-K ↗
2025-04-30—▼ -2.63%8-K ↗
2025-02-26—▲ +4.38%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Congressional trades

all activity →

1 buy · 1 sell · 1 member · last 180d

+$0.00 net boughtlast trade 124d ago
$8.00K bought$8.00K sold
2026-04-07Gilbert CisnerosBuy$1.00K–$15.0KPTR ↗
2026-01-12Gilbert CisnerosSell$1.00K–$15.0KPTR ↗
2024-01-07Josh GottheimerBuy$1.00K–$15.0KPTR ↗

Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score70 vs 67
Revenue growth18.2% vs 7.5%
Net margin11.7% vs 10.0%
Return on equity21.5% vs 12.0%
P/E55.6 vs 26.2